Denatonium acetate monohydrate clinical trials
Also written ARD-101.
A product of Denatonium; its studies count on that page too.
How each study uses denatonium acetate monohydrate is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorisations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Development codes
- ARD-101
- 5
Studies by the year they started
5 studies that test it; most in 2022 (2)
| Year | Studies |
|---|---|
| 2021 | 1 |
| 2022 | 2 |
| 2024 | 2 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 5 · Other 0
Aardvark Therapeutics, Inc. (5)
Related medicines
As reviewed, each with the page that says it.
- A salt or form of Denatonium
Studies
Open first, then newest update. How each study uses denatonium acetate monohydrate is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 5
- A Study of Oral ARD-101 in Patients With Prader-Willi SyndromeCompletedPhase 2Aardvark Therapeutics, Inc.NCT05153434Written as ARD-101
- ARD-101 for Treatment of PWS: The Hunger Elimination or Reduction Objective TrialTerminatedPhase 3Aardvark Therapeutics, Inc.NCT06828861Written as ARD-101
- The Hunger Elimination or Reduction Objective (HERO ) Open -Label Extension (OLE) TrialTerminatedPhase 3Aardvark Therapeutics, Inc.NCT07197034Written as ARD-101
- Study to Evaluate ARD-101 in Adults Receiving Bariatric SurgeryCompletedPhase 2Aardvark Therapeutics, Inc.NCT05215847Written as ARD-101
- Study to Evaluate ARD-101 in Adults With ObesityCompletedPhase 2Aardvark Therapeutics, Inc.NCT05121441Written as ARD-101
Codes
What other systems call denatonium acetate monohydrate · ClinicalTrials.gg INT018584
- UNII (FDA) YE84H43CRFDENATONIUM ACETATE MONOHYDRATEOne source FDA
- NCI Thesaurus C216914Denatonium Acetate MonohydrateOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | YE84H43CRF | DENATONIUM ACETATE MONOHYDRATE | One source FDA |
| NCI Thesaurus | C216914 | Denatonium Acetate Monohydrate | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.